Trial Profile
Phase I/II study of S-1, cisplatin and docetaxel in patients with advanced gastric cancer
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 30 Jun 2016
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Docetaxel (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Gastric cancer
- Focus Adverse reactions; Therapeutic Use
- 11 Sep 2012 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 12 Apr 2011 Planned end date changed from 1 Apr 2009 to 1 Aug 2011 as reported by University Hospital Medical Information Network - Japan.
- 12 Apr 2011 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.